World's Best Scientists 2026 revealed!
Michael P. Manns

Michael P. Manns

Award Badge
Best Scientists
2025
Award Badge
Immunology
Germany
2025

D-Index & Metrics

Best Scientists

D-Index
184
Citations
139911
World Ranking
526
National Ranking
17

Immunology

D-Index
185
Citations
141112
World Ranking
26
National Ranking
1

Medicine

D-Index
187
Citations
145244
World Ranking
282
National Ranking
6

Research.com Recognitions

  • 2025 - Research.com Best Scientists Award
  • 2025 - Research.com Immunology in Germany Leader Award
  • 2025 - Research.com Medicine in Germany Leader Award
  • 2023 - Research.com Immunology in Germany Leader Award
  • 2023 - Research.com Medicine in Germany Leader Award
  • 2022 - Research.com Immunology in Germany Leader Award
  • 2002 - German National Academy of Sciences Leopoldina - Deutsche Akademie der Naturforscher Leopoldina – Nationale Akademie der Wissenschaften Internal Medicine and Dermatology

Overview

Michael P. Manns is affiliated with Hannover Medical School in Germany and has contributed extensively to the field of Medicine, with a strong focus on Hepatology. Their publication record includes 293 works primarily centered on liver diseases and associated medical disciplines.

Their research spans several subfields, including:

  • Hepatology
  • Epidemiology
  • Surgery
  • Infectious Diseases
  • Immunology

Main topics addressed in their work cover:

  • Liver Disease Diagnosis and Treatment
  • Liver Diseases and Immunity
  • Liver Disease and Transplantation
  • Hepatitis B Virus Studies
  • Hepatitis C Virus Research
  • Pediatric Hepatobiliary Diseases and Treatments
  • Gallbladder and Bile Duct Disorders

Michael P. Manns has published multiple papers in frequent venues such as:

  • Journal of Hepatology
  • Liver International
  • Hepatology
  • Hepatology Communications
  • Zeitschrift für Gastroenterologie

Frequent coauthors collaborating on their research include:

  • Heiner Wedemeyer
  • Markus Cornberg
  • Benjamin Maasoumy
  • Stefan Zeuzem
  • Richard Taubert

The following papers represent select recent contributions of Michael P. Manns:

  • Breakthroughs in hepatitis C research: from discovery to cure, 2022, Nature Reviews Gastroenterology & Hepatology
  • The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology, 2020, Journal of Hepatology
  • PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis, 2020, Journal of Hepatology
  • Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases, 2021, Hepatology
  • MicroRNA-342-3p is a potent tumour suppressor in hepatocellular carcinoma, 2020, Journal of Hepatology

Michael P. Manns was awarded membership in the German National Academy of Sciences Leopoldina in 2002, recognized in the fields of Internal Medicine and Dermatology.

Best Publications

  • International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis

    F. Alvarez;P. A. Berg;F. B. Bianchi;L. Bianchi

  • EASL Clinical Practice Guidelines: Management of chronic hepatitis B

    C.P.G.P.P. Marcellin;G. Dusheiko;F. Zoulim;R. Esteban

  • Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

    Sarah Blach;Stefan Zeuzem;Michael Manns;Ibrahim Altraif

  • Diagnosis and management of autoimmune hepatitis.

    Michael P. Manns;Albert J. Czaja;James D. Gorham;Edward L. Krawitt

  • Modeling NAFLD Disease Burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030

    Chris Estes;Quentin M. Anstee;Maria Teresa Arias-Loste;Heike Bantel

  • Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

    Devin Razavi-Shearer;Ivane Gamkrelidze;Mindie H Nguyen;Ding-Shinn Chen

  • Senescence surveillance of pre-malignant hepatocytes limits liver cancer development

    Tae-Won Kang;Tetyana Yevsa;Norman Woller;Lisa Hoenicke

  • Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C.

    Thierry Poynard;John McHutchison;Michael Manns;Christian Trepo

  • Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B

    Patrick Marcellin;E Jenny Heathcote;Maria Buti;Ed Gane

  • Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C

    John G. McHutchison;Michael Manns;Keyur Patel;Thierry Poynard

  • Early virologic response to treatment with peginterferon alfa‐2b plus ribavirin in patients with chronic hepatitis C

    Gary L. Davis;John B. Wong;John G. McHutchison;Michael P. Manns

  • A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells.

    Bastian Hoechst;Lars A. Ormandy;Matthias Ballmaier;Frank Lehner

  • Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C.

    Akinobu Takaki;Manfred Wiese;Geert Maertens;Erik Depla

  • Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma

    Lars A. Ormandy;Tina Hillemann;Heiner Wedemeyer;Michael P. Manns

  • Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases.

    Cara L. Mack;David Adams;David N. Assis;Nanda Kerkar

  • EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure.

    Julia Wendon;Juan Cordoba;Anil Dhawan;Fin Stolze Larsen

  • Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C

    Thierry Poynard;Vlad Ratziu;John McHutchison;Michael Manns

  • Myeloid Derived Suppressor Cells Inhibit Natural Killer Cells in Patients with Hepatocellular Carcinoma via the NKp30 Receptor

    Bastian Hoechst;Torsten Voigtlaender;Lars Ormandy;Jaba Gamrekelashvili

  • Thrombocytopenia associated with chronic liver disease

    Nezam Afdhal;John McHutchison;Robert Brown;Ira Jacobson

  • Sofosbuvir, velpatasvir, and voxilaprevir for previously treated HCV infection

    Marc Bourlière;Stuart C. Gordon;Steven L. Flamm;Curtis L. Cooper

Frequent Co-Authors

Heiner Wedemeyer
Heiner Wedemeyer Hannover Medical School
Markus Cornberg
Markus Cornberg Hannover Medical School
Christian P. Strassburg
Christian P. Strassburg University Hospital Bonn
Christian Trautwein
Christian Trautwein RWTH Aachen University
Hans L. Tillmann
Hans L. Tillmann East Carolina University
Arndt Vogel
Arndt Vogel Hannover Medical School
Stefan Zeuzem
Stefan Zeuzem Goethe University Frankfurt
Tim F. Greten
Tim F. Greten National Institutes of Health
Stephan C. Bischoff
Stephan C. Bischoff University of Hohenheim
Sandra Ciesek
Sandra Ciesek Goethe University Frankfurt

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying immunology can open doors to a variety of healthcare careers, many of which benefit from advanced nursing degrees. For those considering a nursing path, exploring nurse practitioner accelerated program options can be an efficient way to move quickly into advanced practice roles.

If you are already a Family Nurse Practitioner (FNP) looking to specialize, learning how to transition from FNP to acute care NP is a valuable step. This career shift allows professionals to work with critically ill patients, which often demands additional certification and training but offers rewarding opportunities in fast-paced healthcare environments.

Many individuals without prior nursing experience are turning to online accelerated nursing programs for non nurses to start their healthcare journey. These programs provide a direct pathway into nursing, paving the way for future specialization in areas like immunology and acute care.

Compensation is also a critical consideration. Understanding dnp salary variations by state can help prospective students and professionals make informed decisions about where to study and work. This insight ensures alignment between career goals and financial expectations.

Best Scientists Citing Michael P. Manns

Trending Scientists

Recently Published Articles